Breast Cancer Update

Science

Breast Cancer Update

by Dr. Neil Love

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

93 episodes

EN language

All Episodes

1

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

30:21 Mar 18, 2026

2

Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan

16:43 Mar 16, 2026

3

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

58:40 Mar 2, 2026

4

Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

2:01:07 Jan 27, 2026

5

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

1:58:18 Jan 14, 2026

6

Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

1:30:21 Jan 8, 2026

7

Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases

1:00:14 Dec 23, 2025

8

Breast Cancer — Highlights from the 2025 ESMO Annual Meeting

1:27:39 Dec 8, 2025

9

Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

15:27 Dec 5, 2025

10

Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

16:55 Dec 2, 2025

11

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

58:54 Nov 29, 2025

12

Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

12:49 Nov 26, 2025

13

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

58:36 Nov 20, 2025

14

ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs

2:30:36 Nov 14, 2025

15

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

1:57:51 Nov 10, 2025

16

ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders

41:17 Nov 5, 2025

17

Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

15:40 Oct 27, 2025

18

Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates

56:46 Oct 21, 2025

19

HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment

43:40 Oct 14, 2025

20

Breast Cancer — An ASCO 2025 Review

1:02:01 Oct 7, 2025

21

Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

21:51 Sep 29, 2025

22

Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management

40:53 Sep 23, 2025

23

Metastatic Triple-Negative Breast Cancer — The Selection and Sequencing of Therapy

58:41 Sep 18, 2025

24

Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management

54:23 Sep 16, 2025

25

Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management

57:47 Sep 15, 2025

26

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1

58:36 Sep 9, 2025

27

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

15:43 Sep 1, 2025

28

Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches

45:42 Aug 26, 2025

29

Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

20:18 Aug 4, 2025

30

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

27:45 Jul 29, 2025

31

Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

1:57:47 Jul 4, 2025

32

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

54:07 Jun 23, 2025

33

For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress

1:54:49 Jun 16, 2025

34

Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances

1:01:12 Jun 4, 2025

35

5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

13:48 May 28, 2025

36

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

17:35 May 19, 2025

37

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

59:31 May 6, 2025

38

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

1:33:02 Apr 26, 2025

39

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

52:52 Apr 25, 2025

40

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

1:39:35 Apr 21, 2025

41

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

1:59:29 Apr 13, 2025

42

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates

54:56 Apr 8, 2025

43

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

49:28 Mar 28, 2025

44

HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy

1:03:10 Mar 28, 2025

45

5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

16:10 Mar 22, 2025

46

Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management

59:43 Mar 12, 2025

47

5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

18:31 Mar 4, 2025

48

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies

2:02:17 Feb 15, 2025

49

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

10:06 Feb 10, 2025

50

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

11:58 Jan 31, 2025

Select an episode